144 related articles for article (PubMed ID: 15561342)
1. Reduction of morbidity by immunoadsorption therapy in patients with dilated cardiomyopathy.
Knebel F; Böhm M; Staudt A; Borges AC; Tepper M; Jochmann N; Wernicke KD; Felix S; Baumann G
Int J Cardiol; 2004 Dec; 97(3):517-20. PubMed ID: 15561342
[TBL] [Abstract][Full Text] [Related]
2. Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy.
Dandel M; Wallukat G; Englert A; Lehmkuhl HB; Knosalla C; Hetzer R
Eur J Heart Fail; 2012 Dec; 14(12):1374-88. PubMed ID: 22892122
[TBL] [Abstract][Full Text] [Related]
3. Effects of protein A immunoadsorption in patients with advanced chronic dilated cardiomyopathy.
Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Hardt S; Goeser S; Kaya Z; Katus HA; Dengler TJ
J Clin Apher; 2009; 24(4):141-9. PubMed ID: 19591221
[TBL] [Abstract][Full Text] [Related]
4. Effects of immunoadsorption and subsequent immunoglobulin G substitution on cardiopulmonary exercise capacity in patients with dilated cardiomyopathy.
Herda LR; Trimpert C; Nauke U; Landsberger M; Hummel A; Beug D; Kieback A; Dörr M; Empen K; Knebel F; Ewert R; Angelow A; Hoffmann W; Felix SB; Staudt A
Am Heart J; 2010 May; 159(5):809-16. PubMed ID: 20435190
[TBL] [Abstract][Full Text] [Related]
5. Effects of immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy.
Staudt A; Staudt Y; Hummel A; Empen K; Dörr M; Trimpert C; Birkenmeier K; Kühl U; Noutsias M; Russ D; Felix SB
Ther Apher Dial; 2006 Feb; 10(1):42-8. PubMed ID: 16556135
[TBL] [Abstract][Full Text] [Related]
6. The effect of a repeated immunoadsorption in patients with dilated cardiomyopathy after recurrence of severe heart failure symptoms.
Reinthaler M; Empen K; Herda LR; Schwabe A; Rühl M; Dörr M; Felix SB
J Clin Apher; 2015 Aug; 30(4):217-23. PubMed ID: 25346275
[TBL] [Abstract][Full Text] [Related]
7. Role of immunoglobulin G3 subclass in dilated cardiomyopathy: results from protein A immunoadsorption.
Staudt A; Dörr M; Staudt Y; Böhm M; Probst M; Empen K; Plötz S; Maschke HE; Hummel A; Baumann G; Felix SB
Am Heart J; 2005 Oct; 150(4):729-36. PubMed ID: 16209975
[TBL] [Abstract][Full Text] [Related]
8. Immunoadsorption in idiopathic dilated cardiomyopathy, a 3-year follow-up.
Dörffel WV; Wallukat G; Dörffel Y; Felix SB; Baumann G
Int J Cardiol; 2004 Dec; 97(3):529-34. PubMed ID: 15561344
[TBL] [Abstract][Full Text] [Related]
9. A pilot study to assess the use of protein a immunoadsorption for chronic dilated cardiomyopathy.
Cooper LT; Belohlavek M; Korinek J; Yoshifuku S; Sengupta PP; Burgstaler EA; Winters JL
J Clin Apher; 2007; 22(4):210-4. PubMed ID: 17385721
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect of immunoadsorption and subsequent immunoglobulin substitution in patients with dilated cardiomyopathy: Results from the observational prospective Bad Berka Registry.
Ohlow MA; Brunelli M; Schreiber M; Lauer B
J Cardiol; 2017 Feb; 69(2):409-416. PubMed ID: 27890513
[TBL] [Abstract][Full Text] [Related]
11. [Outpatient medical and nurse management program in patients with chronic heart failure in a large territorial area in Piedmont. Four years of follow-up].
Conte MR; Mainardi L; Iazzolino E; Casetta M; Asteggiano R; Lai F; Lusardi R; Sasso L
Ital Heart J Suppl; 2005 Dec; 6(12):812-20. PubMed ID: 16444925
[TBL] [Abstract][Full Text] [Related]
12. The number of regulatory T cells correlates with hemodynamic improvement in patients with inflammatory dilated cardiomyopathy after immunoadsorption therapy.
Bulut D; Creutzenberg G; Mügge A
Scand J Immunol; 2013 Jan; 77(1):54-61. PubMed ID: 22998220
[TBL] [Abstract][Full Text] [Related]
13. Normalization of ejection fraction and resolution of symptoms in chronic severe heart failure is possible with modern medical therapy: clinical observations in 11 patients.
Harinstein ME; Berliner JI; Shah SJ; Taegtmeyer H; Gheorghiade M
Am J Ther; 2008; 15(3):206-13. PubMed ID: 18496257
[TBL] [Abstract][Full Text] [Related]
14. Effect of medical therapy for heart failure on segmental myocardial function in patients with ischemic cardiomyopathy.
Blondheim DS; Kazatsker M; Friedman Z; Lysyansky P; Meisel SR; Asif A; Smirin N; Shotan A
Am J Cardiol; 2007 Jun; 99(12):1741-4. PubMed ID: 17560886
[TBL] [Abstract][Full Text] [Related]
15. Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus.
Dandel M; Englert A; Wallukat G; Riese A; Knosalla C; Stein J; Hetzer R
Atheroscler Suppl; 2015 May; 18():124-33. PubMed ID: 25936316
[TBL] [Abstract][Full Text] [Related]
16. Value of medical therapy in patients >80 years of age with heart failure and preserved ejection fraction.
Tehrani F; Phan A; Chien CV; Morrissey RP; Rafique AM; Schwarz ER
Am J Cardiol; 2009 Mar; 103(6):829-33. PubMed ID: 19268740
[TBL] [Abstract][Full Text] [Related]
17. Specific immunoadsorption therapy using a tryptophan column in patients with refractory heart failure due to dilated cardiomyopathy.
Nagatomo Y; Baba A; Ito H; Naito K; Yoshizawa A; Kurita Y; Nakamura I; Monkawa T; Matsubara T; Wakabayashi Y; Ogawa S; Akaishi M; Yoshikawa T
J Clin Apher; 2011; 26(1):1-8. PubMed ID: 21312253
[TBL] [Abstract][Full Text] [Related]
18. Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study.
Staudt A; Hummel A; Ruppert J; Dörr M; Trimpert C; Birkenmeier K; Krieg T; Staudt Y; Felix SB
Am Heart J; 2006 Oct; 152(4):712.e1-6. PubMed ID: 16996843
[TBL] [Abstract][Full Text] [Related]
19. Survival of patients with familial dilated cardiomyopathy on optimal heart failure therapy.
Martins E; Cardoso JS; Campelo M; Amorim S; Moura B; Maciel MJ; Gonçalves FR
Rev Port Cardiol; 2009 Mar; 28(3):263-8. PubMed ID: 19480309
[TBL] [Abstract][Full Text] [Related]
20. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy.
Staudt A; Böhm M; Knebel F; Grosse Y; Bischoff C; Hummel A; Dahm JB; Borges A; Jochmann N; Wernecke KD; Wallukat G; Baumann G; Felix SB
Circulation; 2002 Nov; 106(19):2448-53. PubMed ID: 12417541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
